Keywords:
Lung, CT, Audit and standards, Outcomes
Authors:
A. Ajjikuttira, M. Peters, K. Dobeli, P. Sharma, K. Steinke
DOI:
10.26044/ranzcr2023/C-170
Results
100 patients (50 male, 50 female, ranging from 33 years to 84 years of age) were included in this series. Patients had pulmonary nodules discovered on a variety of imaging modalities (77 via whole lung CT, 8 via partial lung CT and 15 via nuclear medicine studies).
Patients underwent an average of 4 imaging studies as part of identification and follow-up of their pulmonary nodules, with an average associated cost of AUD$1,699.69 and an average estimated effective dose of 5.7 millisieverts (mSV).
49/100 patients (49%) had benign, stable nodules, 9/100 patients (9%) had resolution of their nodules and 10/100 patients (10%) were discharged to their GP for ongoing monitoring. 3/100 patients (3%) were diagnosed with lung metastases from a non-pulmonary malignancy and 2/100 patients (2%) were diagnosed with primary lung cancer.